Kapiva strengthens R&D, Ameve Sharma appoints R Govindarajan as chief innovation officer

Holistic wellness brand Kapiva appointed R Govindarajan as chief innovation officer at the business. Govindarajan’s appointment is designed to strengthen Kapiva’s research and development and enhance its product quality.

“We are thrilled to welcome Dr. Govind to the Kapiva family,” said Kapiva’s co-founder Ameve Sharma in a press release on October 13. “His extensive experience and profound knowledge of natural products and research and development are perfectly aligned with our commitment to offering authentic, science-backed Ayurvedic products to our consumers. Under Dr. Govind’s leadership, we foresee taking significant strides in crafting products that are highly efficacious and will enable us to compete alongside conventional medical practices. Every step we take in our R&D initiatives brings us closer to reshaping the healthcare standards.”
 
Govindarajan has extensive experience in research and development and has a portfolio of 10 patents and 75 research papers published in numerous esteemed peer-reviewed journals, Kapiva announced. Govindarajan holds a Ph.D. in natural products and he will pursue product development in line with Kapiva’s brand philosophy of making Ayurveda accessible to everyone.

“I am excited to join Kapiva, a brand that is at the forefront of making Ayurveda accessible and modern,” said Govindarajan. “Kapiva’s mission resonates with my own passion for research and innovation in the healthcare sector. I am eager to contribute to the brand’s growth and help further establish Kapiva as a leader in holistic healthcare, enriching lives around the world.”